• About OrPha Swiss
      Slideshow Bild

      About OrPha Swiss

      OrPha Swiss is a Swiss pharmaceutical company focusing primarily on drug therapy for rare diseases ("orphan diseases") and on drugs that are "orphaned" in Switzerland or occupy only small, niche positions.



    A Pioneer in Rare Diseases

    As a specialist in rare diseases, we focus primarily on the therapeutic areas of hemato-oncology, pulmonary hypertension and intensive care medicine. In so doing, we place particular emphasis on providing a comprehensive range of services for our clients in their patient care. This includes a permanent availability and on-the-spot support for specialists. OrPha Swiss cooperates closely with international pharmaceutical companies and supports them in the development of new products for the treatment of rare diseases. If you would like to know more about OrPha Swiss we look forward to hearing from you.